Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2

Microbial Pathogenesis

Volumn 34, Issue 1, 2003, Pages 27-37

  Lun, Shichun ^a   Perez Casal, Jose ^a   Connor, Wayne ^a   Willson, P J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Aerosol challenge; Bactericidal test; Cytokine production; Pig model; Streptococcus suis; Suilysin

Indexed keywords

BACTERIAL PROTEIN; BACTERICIDE; CELL SURFACE PROTEIN; CYTOLYSIN; HEMOLYSIN; INTERLEUKIN 6; RECOMBINANT PROTEIN; SUILYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE DISEASE; AEROSOL; ALLELE; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BACTERIUM MUTANT; BRAIN TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESCHERICHIA COLI; FEVER; GENE EXPRESSION; HEART; HUMAN; HUMAN CELL; IMMUNITY; JOINT; LIVER; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MALE; MOLECULAR CLONING; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT INFECTION; SEPTICEMIA; SEROTYPE; SOUTHERN BLOTTING; SPLEEN; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; SUBMANDIBULAR GLAND; SWINE; TISSUE; WESTERN BLOTTING; WILD TYPE;

ANIMALIA; STRAWBERRY LETHAL YELLOWS PHYTOPLASMA; STREPTOCOCCUS; STREPTOCOCCUS SUIS; SUS SCROFA;

EID: 0037215998     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0882-4010(02)00192-4     Document Type: Article

References (46)

1. Staats J.J., Feder I., Okwumabua O., Chengappa M.M. Streptococcus suis: past and present. Vet Res Commun. 21:1997;381-407.
2. Chanter N., Jones P.W., Alexander T.J.L. Meningitis in pigs caused by Streptococcus suis - a speculative review. Vet Microbiol. 36:1993;39-55.
3. Jacobs A.A.C., Loeffen P.L.W., Berg A.J.G., Storm P.K. Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect Immun. 62:1994;1742-1748.
4. Jacobs A.A.C., Berg A.J.G., Baars J.C., Nielsen B., Johannsen L.W. Production of suilysin, the thiol-activated haemolysin of Streptococcus suis, by field isolates from diseased pigs. Vet Record. 137:1995;295-296.
5. Higgins R., Gottschalk M. Distribution of Streptococcus suis capsular types in 2000. Can Vet J. 41:2001;223.
6. Arends J.P., Harwig N., Rudolphy M., Zanen H.C. Carrier rate of Streptococcus suis capsular type 2 in palatine tonsils of slaughtered pigs. J Clin Microbiol. 20:1984;945-947.
7. Mwaniki C.G., Robertson I.D., Trott D.J., Atyeo R.F., Lee B.J., Hampson D.J. Clonal analysis and virulence of Australian isolates of Streptococcus suis type 2. Epidemiol Infect. 113:1994;321-334.
8. Salles M.W.S., Perez-Casal J., Willson P., Middleton D.M. Changes in the leukocyte subpopulations of the palatine tonsillar crypt epithelium of pigs in response to Streptococcus suis type 2 infection. Vet Immunol Immunopathol. 87:2002;51-63.
9. Vecht U., Wisselink H.J., Jellema M.L., Smith H.E. Identification of two proteins associated with virulence of Streptococcus suis Type 2. Infect Immun. 59:1991;3156-3162.
10. Vecht U., Wisselink H.J., Dijk J.E., Smith H.E. Virulence of Streptococcus suis Type 2 strains in newborn germfree pigs depends on phenotype. Infect Immun. 60:1992;550-556.
11. Smith H.E., Vecht U., Wisselink H.J., Stockhofe-Zurwieden N., Biermann Y., Smiths M.A. Mutants of Streptococcus suis Type 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs. Infect Immun. 64:1996;4409-4412.
12. Charland N., Kobisch M., Martineau-Doize B., Jacques M., Gottschalk M. Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2. FEMS Immunol Med Microbiol. 14:1996;195-203.
13. Charland N., Harel J., Kobisch M., Lacasse S., Gottschalk M. Streptococcus suis serotype 2 mutants deficient in capsular expression. Microbiology. 144:1998;325-332.
14. Smith H.E., Damman M., Velde J., Wagenaar F., Wisselink H.J., Stockhole-zurwieden N., Smits M.A. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect Immun. 67(4):1999;1750-1756.
15. Greeff A., Buys H., Verhaar R., Dijkstra J., Alphen L., Smith H.E. Contribution of fibronectin-binding protein to pathogenesis of Streptococcus suis serotype 2. Infect Immun. 70:2002;1319-1325.
16. Gottschalk M.G., Lacouture S., Dubreuil D. Characterization of Streptococcus suis capsular type 2 haemolysin. Microbiology. 141:1995;189-195.
17. Tweten R.K. Pore-forming toxins of Gram-positive bacteria. Roth J.A. Virulence mechanisms of bacterial pathogens. 1995;207-229 American Society for Microbiology, Washington, DC.
18. Staats J.J., Plattner B.L., Stewart G.C., Chengappa M.M. Presence of the Streptococcus suis suilysin gene and expression of MRP and EF correlates with high virulence in Streptococcus suis type 2 isolates. Vet Microbiol. 70:1999;201-211.
19. Norton P.M., Rolph C.R., Ward P.N., Bentley R.W., Leigh J.A. Epithelial invasion and cell lysis by virulent strains of Streptococcus suis is enhanced by the presence of suilysin. FEMS Immun Med Microbiol. 26:1999;25-35.
20. Lalonde M., Segura M., Lacouture S., Gottschalk M. Interaction between Streptococcus suis serotype 2 and different epithelial cell lines. Microbiology. 146:2000;1913-1921.
21. Jacobs A.A.C., Berg A.J.G., Loeffen P.L.W. Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis. Vet Record. 139:1996;225-228.
22. King S.J., Heath P.J., Luque I., Tarradas C., Dowson C.G., Whatmore A.M. Distribution and Genetic diversity of suilysin in Streptococcus suis isolated from different diseases of pigs and characterization of the genetic basis of suilysin absence. Infect Immun. 69:2001;7572-7582.
23. Vecht U., Stockholfe-Zurwieden N., Tebenburg B., Wisselink H.J., Smith H.E. Virulence of Streptococcus suis type 2 for mice and pigs appeared host-specific. Vet Microbiol. 58:1997;53-60.
24. Vecht U., Stockholfe-Zurwieden N., Tebenburg B., Wisselink H.J., Smith H.E. Murine and pig models of Streptococcus suis type 2 infection are incompatible. Adv Exp Med Biol. 418:1997;827-829.
25. Allen A.G., Bolitho S., Lindsay H., Khan S., Bryant C., Norton P., Ward P., Leigh J., Morgan J., Riches H., Eastty S., Maskell D. Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin. Infect Immun. 69(4):2001;2732-2735.
26. Pinkney M., Beachey E., Kehoe M. The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect Immun. 57:1989;2553-2558.
27. Segers R.P.A.M., Kenter T., Haan L.A.M., Jacobs A.A.C. Characterization of the gene encoding suilysin from Streptococcus suis and expression in field strains. FEMS Microbiol Lett. 167:1998;255-261.
28. Gottschalk M., Higgins R., Jacques M., Dubreuil D. Production and characterization of two Streptococcus suis capsular type 2 mutants. Vet Microbiol. 30:1992;59-71.
29. Salasia S.I., Lammler C., Herrmann G. Properties of a Streptococcus suis isolate of serotype 2 and two capsular mutants. Vet Microbiol. 45:1995;151-156.
30. Brazeau C., Gottschalk M., Vincelette S., Martineau-Doize B. In vitro phagocytosis and survival of Streptococcus suis capsular type 2 inside murine macrophages. Microbiology. 142:1996;1231-1237.
31. Takamatsu D., Osaki M., Sekizaki T. Evidence for lateral transfer of the suilysin gene region of Streptococcus suis. J Bacteriol. 184:2002;2050-2057.
32. Segra M., Stankova J., Gottschalk M. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages. Infect Immun. 67:1999;4646-4654.
33. Furth A.M., Roord J.J., van Furth R. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun. 64:1996;4883-4890.
34. Khan A.Q., Shen Y., Wu Z.Q., Wynn T.A., Snapper C.M. Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun. 70:2002;749-761.
35. Segura M., Vadeboncoeur N., Gottschalk M. CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin Exp Immunol. 127:2002;243-254.
36. Benkirane R., Gottschalk M.G., Jacques M., Dubreuil J.D. Immunochemical characterization of an IgG-binding protein of Streptococcus suis. FEMS Immunol Med Microbiol. 20:1998;121-127.
37. Gottschalk M., Lebrun A., Wisselink H., Dubreuil D., Smith H., Vecht U. Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can J Vet Res. 62:1998;75-79.
38. Brown T. Analysis of DNA sequences by blotting and hybridization. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Struhl K. Current protocols in molecular biology. vol. I:1999;2.9.1-2.9.20 Wiley, New York.
39. Huang H., Potter A.A., Campos M., Leighton F.A., Willson P.J., Yates W.D.G. Pathogenesis of porcine Actinobacillus pleuropneumonia: Part I. Effects of surface components of Actinobacillus pleuropneumoniae in vitro and in vivo. Can J Vet Res. 62:1998;93-101.
40. Flick D.A., Gifford G.E. Comparison of in vitro cell cytotoxic assay for tumor necrosis factor. J Immunol. 68:1984;167-175.
41. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:1983;55-63.
42. Hopkins S.J., Humphreys M. Simple, sensitive and specific bioassay of interleukin-1. J Immunol Methods. 120:1989;271-276.
43. Perez-Casal J., Price J.A., Maguin E., Scott J.R. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol Microbiol. 8:1993;809-819.
44. Guide to the care and use of experimental animals. vol. 2:1984;. p. 1980-4.
45. Pettersson A., van der Ley P., Poolman J.T., Tommassen J. Molecular characterization of the 98-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis. Infect Immun. 61:1993;4724-4733.
46. Rossi-Campos A., Anderson C., Gerlach G.F., Klashinsky S., Potter A.A., Willson P.J. Immunization of pigs against Actinobacillus pleuropneumoniae with two recombinant protein preparations. Vaccine. 10:1992;512-518.